Morbidity and mortality associated with arterial surgery site infections by resistant microorganisms
Morbimortalidade relacionada às infecções de ferida operatória ocasionadas por micro-organismos resistentes em cirurgias arteriais
Eduardo Lichtenfels; Pedro Alves D'Azevedo; Airton Delduque Frankini; Nilon Erling Jr.; Newton Roesch Aerts
Abstract
Keywords
Resumo
Palavras-chave
References
Frankini AD, Cardozo MA, Lichtenfels E. Cirurgia Vascular. Infecção em Prótese Vascular. 2008:866-83.
Moreira RCR. Infecção local pós-operatória em cirurgia arterial. Cir Vasc Angiol. 1995;11:46-54.
Bandyk DF. Vascular Surgery. Infection in Prosthetic Vascular Grafts. 2000:733-51.
França LHG, Stahlke HJ, Garschagen MT, Parchen CFR. Fatores de risco associados à infecção, amputação e mortalidade em pacientes submetidos a pontes arteriais infra-inguinais. Estudo retrospectivo de 27 casos. J Vasc Bras. 2004;3:214-22.
Moreira RCR. Doenças Vasculares Periféricas. Infecção em Próteses Vasculares. 2002:931-42.
Naylor AR, Hayes PD, Darke S. A prospective audit of complex wound and graft infections in Great Britain and Ireland: the emergence of MRSA. Eur J Vasc Endovasc Surg. 2001;21(4):289-94.
Terpstra S, Noordhoek GT, Voesten HGJ, Hendriks B, Degener JE. Rapid emergence of resistant coagulase-negative staphylococci on the skin after antibiotic prophylaxis. J Hosp Infect. 1999;43(3):195-202.
Cardozo MA, Frankini AD, Bonamigo TP. Use of superficial femoral vein in the treatment of infected aortoiliofemoral prosthetic grafts. Cardiovasc Surg. 2002;10(4):304-10.
Styers D, Sheehan DJ, Hogan P, Sahm DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob. 2006;5(1):2-9.
Lichtenfels E, Lucas ML, Webster R, D'Azevedo PA. Profilaxia antimicrobiana em cirurgia vascular periférica: cefalosporina ainda é o padrão-ouro?. J Vasc Bras. 2007;6(4):378-87.
Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN, Abarca Aguilar F. Nosocomial MRSA infection in vascular surgery patients: impact on patient outcome. Vasc Endovascular Surg. 2005;39(4):327-34.
Taylor MD, Napolitano LM. Methicillin-resistant Staphylococcus aureus infections in vascular surgery: increasing prevalence. Surg Infect (Larchmt). 2004;5(2):180-7.
Cerveira JJ, Lal BK, Padberg Jr FT, Pappas PJ, Hobson 2nd RW. Methicillin-resistant Staphylococcus aureus infection does not adversely affect clinical outcome of lower extremity amputations. Ann Vasc Surg. 2003;17(1):80-5.
Menon KV, Whiteley MS, Burden P, Galland RB. Surgical patients with methicillin resistant staphylococcus aureus infection: an analysis of outcome using P-POSSUM. J R Coll Surg Edinb. 1999;44(3):161-3.
Performance standards for antimicrobial susceptibility testing, sixteenth informational supplement, document M100-S16. 2006.
Szilagyi DE, Smith RF, Elliott JP, Vrandecic MP. Infection in arterial reconstruction with synthetic grafts. Ann Surg. 1972;176(3):321-3.
Jones RN. Global aspects of antimicrobial resistance among key bacterial pathogensresults from the 1997-2001 SENTRY Antimicrobial Program. Semin Respi Clin Infect Dis. 2001;32:S81-156.
National Nosocomial Infections Surveilliance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control. 2004;32(8):470-85.
Murray PR, Rosenthal KS, Pfaller MA. Microbiologia Médica. 2006.
Kang CI, Kim SH, Park WB. Bloodstream infections caused by antibiotic-resistant gram-negative bacilli: risk factors for mortality and impact of inappropriate initial antimicrobial therapy on outcome. Antimicrob Agents Chemother. 2005;49(2):760-6.
Chambers HF. The changing epidemiology of Staphylococcus aureus?. Emerg Infect Dis. 2001;7(2):178-82.
McGowan Jr JE. Economic impact of antimicrobial resistance. Emerg Infect Dis. 2001;7(2):286-92.
Cruse PJ, Foord R. The epidemiology of wound infection. A 10-year prospective study of 62,939 wounds. Surg Clin North Am. 1980;60(1):27-40.
Dellinger EP. Sabiston: Tratado de Cirurgia. Infecções cirúrgicas e escolha dos antimicrobianos. 2003:182-200.
Fry DE. Surgical infections. 1995.
Howard RJ, Simmons RL. Surgical infectious disease. 2008.
Linton RR. The prophylactic use of the antibiotics in clean surgery. Surg Gynecol Obstet. 1961;112:218-20.
Reifsnyder T, Bandyk D, Seabrook G, Kinney E, Towne JB. Wound complications of the in situ saphenous vein bypass technique. J Vasc Surg. 1992;15(5):843-50.
Rubin JR, Malone JM, Goldstone J. The role of the lymphatic system in acute arterial prosthetic graft infections. J Vasc Surg. 1985;2(1):92-8.
Levy MF, Schmitt DD, Edmiston CE. Sequential analysis of staphylococcal colonization of body surfaces of patients undergoing vascular surgery. J Clin Microbiol. 1990;28(4):664-9.
Wengrovitz M, Atnip RG, Gifford RRM, Neumyer MM, Heitjan DF, Thiele BL. Wound complications of autogenous subcutaneous infrainguinal arterial bypass surgery: predisposing factors and management. J Vasc Surg. 1990;11(1):156-63.
Bandyk DF, Kinney EV, Riefsnyder TI, Kelly H, Towne JB. Treatment of bacteria-biofilm graft infection by in situ replacement in normal and immune-deficient states. J Vasc Surg. 1993;18(3):398-406.
Bergamini TM, Bandyk DF, Govostis D, Vetsch R, Towne JB. Identification of Staphylococcus epidermidis vascular graft infections: a comparison of culture techniques. J Vasc Surg. 1989;9(5):665-70.
Hicks RCJ, Greenhalgh RM. The pathogenesis of vascular graft infection. Eur J Vasc Endovasc Surg. 1997;14(^sSuppl A):5-9.
Moreira RCR. Estudo bacteriológico de linfonodos inguinais de pacientes submetidos à cirurgia arterial. 1991.
Timi JRR. Estudo bacteriológico da placa aterosclerótica da artéria femoral. 1992.